Heard of Axelia Solutions or Aarman Solutions? They may not ring a bell, but they are vital to the business of PharmEasy, India’s leading online pharmacy and healthcare platform.
The two companies operate the platform, including the mobile app and website. PharmEasy’s well-known parent, API Holdings Limited, does not perform this function.
Confused? That’s the complex structure of API Holdings, which filed papers for a Rs 6,250-crore IPO last month, becoming the youngest Indian unicorn to make the public-market move.
API has over two dozen subsidiaries, thanks to a string of acquisitions it has made to build out the business in a heavily regulated market. Aarman and Axelia, however, do not figure among the subsidiaries. API has a shade below 20% stake in Aarman, which owns Axelia.
PharmEasy is run in this complicated manner because it has to comply with the wide-ranging rules governing foreign direct investment. India does not allow FDI in inventory-based models; outside money is permitted in only marketplace models.
This is a premium article and available only to subscribers.
Exclusive access to this article for 1 year.
What you get
Premium In-Depth Stories
5 articles every week
Archives
>3 years of archives
Newsletter
5 every week
Gifting Credit
5 premium articles every month
Visual Infographics
1 every week
Sessions
3 screens Concurrently
Upgrade how you think, work, and win — Freedom Sale is on!
Have a coupon code?
Access unlimited content at a special discounted rate. Trusted by top VC’s and leading organizations, we provide bulk subscriptions for groups of 30+. Contact us for more details
Top educational institutions have collaborated with us for campus-wide subscriptions. For bulk campus-wide access, please get in touch.
Join our community of 100,000+ top executives, VCs, entrepreneurs, and brightest student minds
Convinced that The Captable stories and insights
will give you the edge?
Convinced that The Captable stories
and insights will give you the edge?
Subscribe Now
Sign Up Now